Zymeworks shareholder EcoR1 Capital disclosed in a regulatory filing that it had purchased 307.5K shares of Zymeworks between January 19 and January 20 for a total transaction amount of $3.0M. Shares of Zymeworks are up 3.2% afterhours at $9.71.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ZYME:
- Zymeworks price target raised to $16 from $15 at Guggenheim
- Jazz Pharmaceuticals, Zymeworks report 84% survival for zanidatamab in mGEA
- This Insider Just Spiked Investors’ Interest in Zymeworks (NASDAQ:ZYME) Stock
- Zymeworks up 4% afterhours as holder EcoR1 Capital buys $9.7M in common stock
- Zymeworks (NASDAQ:ZYME) Stock: Insider Buys Shares Worth $8M
